BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 35117392)

  • 1. Identification of key candidate genes and pathways in follicular variant papillary thyroid carcinoma by integrated bioinformatical analysis.
    Jing L; Xia F; Du X; Jiang B; Chen Y; Li X
    Transl Cancer Res; 2020 Feb; 9(2):477-490. PubMed ID: 35117392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of novel target genes and pathways involved in tall cell variant papillary thyroid carcinoma.
    Xia F; Jiang B; Chen Y; Du X; Peng Y; Wang W; Wang Z; Li X
    Medicine (Baltimore); 2018 Dec; 97(51):e13802. PubMed ID: 30572540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular genotyping of follicular variant of papillary thyroid carcinoma correlates with diagnostic category of fine-needle aspiration cytology: values of RAS mutation testing.
    Lee SR; Jung CK; Kim TE; Bae JS; Jung SL; Choi YJ; Kang CS
    Thyroid; 2013 Nov; 23(11):1416-22. PubMed ID: 23590130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic alterations in the RAS/RAF/mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signaling pathways in the follicular variant of papillary thyroid carcinoma.
    Santarpia L; Myers JN; Sherman SI; Trimarchi F; Clayman GL; El-Naggar AK
    Cancer; 2010 Jun; 116(12):2974-83. PubMed ID: 20564403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mutation of RAS gene in follicular-differentiated thyroid tumors and its significance].
    Liu LP; Hao JY; Pan H; Wang C; Yue P
    Zhonghua Bing Li Xue Za Zhi; 2020 Mar; 49(3):256-261. PubMed ID: 32187898
    [No Abstract]   [Full Text] [Related]  

  • 6. Comprehensive Transcriptomic and Genomic Profiling of Subtypes of Follicular Variant of Papillary Thyroid Carcinoma.
    Song YS; Won JK; Yoo SK; Jung KC; Kim MJ; Kim SJ; Cho SW; Lee KE; Yi KH; Seo JS; Park YJ
    Thyroid; 2018 Nov; 28(11):1468-1478. PubMed ID: 30226444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of
    Kim H; Kim BH; Kim YK; Kim JM; Oh SY; Kim EH; Lee MJ; Kim JH; Jeon YK; Kim SS; Lee BJ; Kim YK; Kim IJ
    J Korean Med Sci; 2018 Jul; 33(27):e75. PubMed ID: 29962924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive MicroRNA expression profiling identifies novel markers in follicular variant of papillary thyroid carcinoma.
    Dettmer M; Perren A; Moch H; Komminoth P; Nikiforov YE; Nikiforova MN
    Thyroid; 2013 Nov; 23(11):1383-9. PubMed ID: 23427895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of histopathological features and prognosis of classical and follicular variant papillary thyroid carcinoma.
    Tunca F; Sormaz IC; Iscan Y; Senyurek YG; Terzioglu T
    J Endocrinol Invest; 2015 Dec; 38(12):1327-34. PubMed ID: 26280320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of Strict Criteria for Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features and Encapsulated Follicular Variant Papillary Thyroid Carcinoma: a Retrospective Study of 50 Tumors Previously Diagnosed as Follicular Variant PTC.
    Point du Jour K; du Jour KP; Schmitt AC; Chen AY; Griffith CC
    Endocr Pathol; 2018 Mar; 29(1):35-42. PubMed ID: 29368294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Follicular variant of papillary thyroid carcinoma (FVPTC): histological features, BRAF V600E mutation, and lymph node status.
    Walts AE; Mirocha JM; Bose S
    J Cancer Res Clin Oncol; 2015 Oct; 141(10):1749-56. PubMed ID: 25702102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The preeminence of growth pattern and invasiveness and the limited influence of BRAF and RAS mutations in the occurrence of papillary thyroid carcinoma lymph node metastases.
    Eloy C; Santos J; Soares P; Sobrinho-Simões M
    Virchows Arch; 2011 Sep; 459(3):265-76. PubMed ID: 21796448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BRAF mutation in follicular variant of papillary thyroid carcinoma is associated with unfavourable clinicopathological characteristics and malignant features on ultrasonography.
    Chai YJ; Kim SJ; Kim SC; Koo do H; Min HS; Lee KE; Kim JH; Youn YK
    Clin Endocrinol (Oxf); 2014 Sep; 81(3):432-9. PubMed ID: 24548081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Follicular variant of papillary carcinoma: reproducibility of histologic diagnosis and utility of HBME-1 immunohistochemistry and BRAF mutational analysis as diagnostic adjuncts.
    Wallander M; Layfield LJ; Jarboe E; Emerson L; Liu T; Thaker H; Holden J; Tripp S
    Appl Immunohistochem Mol Morphol; 2010 May; 18(3):231-5. PubMed ID: 20042852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors of distant metastasis in the follicular variant of papillary thyroid carcinoma.
    Li YR; Chen ST; Hseuh C; Chao TC; Ho TY; Lin JD
    J Formos Med Assoc; 2016 Aug; 115(8):665-71. PubMed ID: 26239193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of candidate genes associated with papillary thyroid carcinoma pathogenesis and progression by weighted gene co-expression network analysis.
    Chen X; Wang R; Xu T; Zhang Y; Li H; Du C; Wang K; Gao Z
    Transl Cancer Res; 2021 Feb; 10(2):694-713. PubMed ID: 35116402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increasing diagnosis of thyroid papillary carcinoma follicular variant in south-east Anatolian region: comparison of characteristics of classical papillary and follicular variant thyroid cancers.
    Ertek S; Yılmaz NC; Cicero AF; Vurupalmaz Ö; Demiröz AS; Erdoğan G
    Endocr Pathol; 2012 Sep; 23(3):157-60. PubMed ID: 22711546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioinformatics analysis to screen key genes in papillary thyroid carcinoma.
    Liu Y; Gao S; Jin Y; Yang Y; Tai J; Wang S; Yang H; Chu P; Han S; Lu J; Ni X; Yu Y; Guo Y
    Oncol Lett; 2020 Jan; 19(1):195-204. PubMed ID: 31897130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Profiling of Follicular Variant of Papillary Thyroid Cancer Reveals Low-Risk Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features: A Paradigm Shift to Reduce Aggressive Treatment of Indolent Tumors.
    George N; Agarwal A; Kumari N; Agarwal S; Krisnani N; Gupta SK
    Indian J Endocrinol Metab; 2018; 22(3):339-346. PubMed ID: 30090725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Tissue-Specific Expressed Hub Genes and Potential Drugs in Rheumatoid Arthritis Using Bioinformatics Analysis.
    Xing X; Xia Q; Gong B; Shen Z; Zhang Y
    Front Genet; 2022; 13():855557. PubMed ID: 35368701
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.